wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49873786-740A5269-6CAA-49FD-BEF3-549D56C89FB3
Q49873786-740A5269-6CAA-49FD-BEF3-549D56C89FB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49873786-740A5269-6CAA-49FD-BEF3-549D56C89FB3
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States.
P2860
Q49873786-740A5269-6CAA-49FD-BEF3-549D56C89FB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49873786-740A5269-6CAA-49FD-BEF3-549D56C89FB3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d140ac3ce4a7820420d8a377775ea317dd5b49c8
P2860
Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes.